Routes of
administration Oral PubChem CID 18687754 Formula C14H8F4O4S | ATC code none ChemSpider 13701383 | |
 | ||
Legal status In general: uncontrolled | ||
CX157 (proposed trade name TriRima, formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA). As of 2007 it was in phase II clinical trials for the treatment of depression. In 2013, it was discontinued for both depression and anxiety.[1]
References
CX157 Wikipedia(Text) CC BY-SA